Senseonics Holdings, Inc.

About Senseonics Holdings, Inc.

Senseonics is a company focused on creating innovative diabetes management solutions, notably as the creators of the first and only long-term implantable Continuous Glucose Monitoring (CGM) system.

Products & Services

Eversense Continuous Glucose Monitoring System:A long-term implantable CGM system with variants lasting up to 180 days and 365 days, designed to monitor glucose levels in diabetes patients.

Specialties

Continuous Glucose Monitoring (CGM) Implantable Medical Devices Diabetes Management

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 140000000 MR: - FA: $140 million FAN: 140000000	D: 2026-05-04 FD: 2026-05-04	1 investors
2	RT: Public Offering T: - FT: Public Offering	A: 92000000 MR: - FA: $92 million FAN: 92000000	D: 2026-05-04 FD: 2026-05-04	4 investors
3	RT: Public Offering T: - FT: Public Offering	A: 80000000 MR: - FA: 80 Million FAN: 80000000	D: 2026-04-30 FD: 2026-04-30	4 investors
4	RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement	A: 57500000 MR: - FA: $57.5 million FAN: 57500000	D: 2025-05-21 FD: 2025-05-21	5 investors
5	RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2025-05-15 FD: 2025-05-15	5 investors
6	RT: Public Offering T: - FT: Public Offering	A: 50000000 MR: - FA: $50 Million FAN: 50000000	D: 2025-05-15 FD: 2025-05-15	5 investors
7	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 16000000 MR: - FA: 16 million FAN: 16000000	D: 2024-10-25 FD: 2024-10-25	-

Debt Latest

2026-05-04

$140.0M

1 investor (Pro only)

Public Offering 2026-05-04

$92.0M

Public Offering 2026-04-30

$80.0M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stephen P. DeFalco

Director and Chairman

E

Edward J. Fiorentino

Executive Chairman at TerSera Therapeutics

F

Fran Kaufman

Chief Medical Officer and Director

S

Sharon D. Larkin

Board of Directors

D

Douglas S. Prince

Board of Directors

D

Douglas A. Roeder

Partner at Delphi Ventures

View 11 more team members with Pro

Unlock Full Team Directory

Recent News